PRE 14A

PROXY STATEMENT

Company: Semnur Pharmaceuticals, Inc.
Filed: June 18, 2024
Period of Report: June 18, 2024
Accession Number: 0001213900-24-053865

View Document ↗ View on SEC.gov ↗